TAP2: Transporter Associated with Antigen Processing 2
Key component of the MHC class I antigen presentation pathway; mutations linked to immunodeficiency and autoimmune disorders.
Gene Information Card
| Symbol | TAP2 |
|---|---|
| Full Name | Transporter associated with antigen processing 2 |
| Gene Type | Protein coding |
| Chromosomal Location | 6p21.32 |
| NCBI Gene ID | 6891 ncbi.nlm.nih.gov/gene/6891 |
| Ensembl ID | ENSG00000204267 |
| UniProt ID | Q03519 |
| OMIM ID | 170261 |
| HGNC ID | 43 |
| Aliases | ABCB3, PSF2, RING11, TAP2*01, TAP2*02 |
Description
The TAP2 gene encodes a subunit of the transporter associated with antigen processing (TAP) complex, which is essential for peptide translocation from the cytosol into the endoplasmic reticulum for loading onto MHC class I molecules. TAP2 forms a heterodimer with TAP1, and together they function as an ATP-binding cassette (ABC) transporter. Mutations in TAP2 impair antigen presentation, leading to immunodeficiency syndromes such as bare lymphocyte syndrome type I and increased susceptibility to infections and autoimmune conditions.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Bare lymphocyte syndrome type I | Loss-of-function mutations in TAP2 disrupt peptide transport, reducing MHC class I surface expression and impairing CD8+ T-cell immunity. | ClinVar, OMIM |
| Autoimmune disease (e.g., rheumatoid arthritis, type 1 diabetes) | TAP2 polymorphisms may alter antigen presentation, influencing T-cell selection and autoimmune risk. | NCBI Gene, OMIM |
| Immunodeficiency with recurrent infections | Defective TAP2 leads to decreased MHC class I expression, compromising antiviral and antitumor immune responses. | ClinVar, OMIM |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lymph node | 12.5 | Medium |
| Spleen | 10.8 | Medium |
| Lung | 8.3 | Low |
| Small intestine | 7.1 | Low |
| Liver | 5.9 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 15.2 | High expression in embryonic kidney cells |
| HeLa | 12.0 | Moderate expression in cervical cancer cells |
| K562 | 9.8 | Moderate expression in leukemia cells |
| HepG2 | 7.5 | Low expression in liver cancer cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1478C>T (p.Thr493Ile) | Missense | Rare | Reduced peptide transport activity; associated with bare lymphocyte syndrome |
| c.1643G>A (p.Arg548Gln) | Missense | Rare | Impaired TAP complex assembly; linked to immunodeficiency |
| c.1976delA (p.Lys659Argfs*2) | Frameshift | Very rare | Loss of function; truncation of C-terminal domain |
Mutation functional classification
Loss of Function (LOF)
Most TAP2 mutations (missense, nonsense, frameshift) result in loss of peptide transport activity, leading to bare lymphocyte syndrome type I.
Gain of Function (GOF)
No gain-of-function mutations reported in TAP2.
Dominant Negative (DN)
No dominant-negative mutations reported; TAP2 deficiency is typically recessive.
View complete mutation data:
Gene Ontology (GO)
| • ATP binding | • ATP hydrolysis activity |
| • peptide antigen transport | • MHC class I protein complex assembly |
| • endoplasmic reticulum membrane | • transmembrane transporter activity |
Pathways
• Antigen processing and presentation (KEGG hsa04612)
• MHC class I antigen presentation (Reactome R-HSA-983170)
Protein Summary
TAP2 is a 703-amino acid ABC transporter subunit that, together with TAP1, forms a heterodimeric peptide transporter in the endoplasmic reticulum membrane. It contains a transmembrane domain (TMD) and a nucleotide-binding domain (NBD). ATP binding and hydrolysis drive conformational changes that allow peptide translocation. TAP2 is essential for loading antigenic peptides onto MHC class I molecules, a critical step in adaptive immunity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TAP2 Knockout HEK293T Cell Line | EDJ-KQ191 | Human | 6891 | Details Get a Quote |
| KRTAP2-4 Knockout HEK293 Cell Line | EDJ-KQ10327 | Human | 85294 | Details Get a Quote |
| KRTAP2-2 Knockout HEK293 Cell Line | EDJ-KQ10328 | Human | 728279 | Details Get a Quote |
| KRTAP22-2 Knockout HEK293 Cell Line | EDJ-KQ12057 | Human | 100288287 | Details Get a Quote |
| KRTAP22-1 Knockout HEK293 Cell Line | EDJ-KQ12067 | Human | 337979 | Details Get a Quote |
| KRTAP23-1 Knockout HEK293 Cell Line | EDJ-KQ12089 | Human | 337963 | Details Get a Quote |
| KRTAP29-1 Knockout HEK293 Cell Line | EDJ-KQ12102 | Human | 100533177 | Details Get a Quote |
| KRTAP20-4 Knockout HEK293 Cell Line | EDJ-KQ12115 | Human | 100151643 | Details Get a Quote |
| KRTAP20-3 Knockout HEK293 Cell Line | EDJ-KQ12116 | Human | 337985 | Details Get a Quote |
| KRTAP20-1 Knockout HEK293 Cell Line | EDJ-KQ12124 | Human | 337975 | Details Get a Quote |
| KRTAP25-1 Knockout HEK293 Cell Line | EDJ-KQ12131 | Human | 100131902 | Details Get a Quote |
| KRTAP2-3 Knockout HEK293 Cell Line | EDJ-KQ13246 | Human | 730755 | Details Get a Quote |
| KRTAP27-1 Knockout HEK293 Cell Line | EDJ-KQ13264 | Human | 643812 | Details Get a Quote |
| KRTAP20-2 Knockout HEK293 Cell Line | EDJ-KQ14011 | Human | 337976 | Details Get a Quote |
| KRTAP21-1 Knockout HEK293 Cell Line | EDJ-KQ14012 | Human | 337977 | Details Get a Quote |
Displaying Records 1 To 15 Of 82 Records
- 1
- 2
- Next Page »